EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation

Verónica Fuentes-Santamaría, Carmen María Díaz García, Juan Carlos Alvarado

Neurodegenerative Diseases · 20.06.2026 · 1-14

DOI: 10.1159/000553216 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neurodegenerative Diseases, online erschienen am 20.06.2026. Verfasst von Verónica Fuentes-Santamaría und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Group on Neurodegenerative Diseases and Their Relationship with Neurosensory Alterations and Aging, Institute of Biomedicine of Castilla-La …. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Hearing impairment has emerged as a consistently associated and potentially modifiable risk factor for cognitive decline and dementia, including Alzheimer’s disease (AD). Epidemiological studies demonstrate an increased dementia risk among individuals with hearing loss, with evidence of dose-response relationships across levels of auditory decline. Despite the robustness of this association, the mechanisms linking auditory dysfunction to cognitive deterioration remain multifactorial and incompletely understood. Summary: By integrating biological, cognitive, and psychosocial perspectives while explicitly addressing persistent uncertainties, this critical narrative review provides a balanced framework for interpreting the relationship between hearing impairment and AD. Current evidence points to several interacting pathways, including sensory deprivation, cortical reorganization, increased cognitive load, and psychosocial consequences like social isolation. Furthermore, emerging research suggests that central auditory processing deficits may represent early functional markers of cortical vulnerability associated with neurodegeneration. Clinically, these insights emphasize the importance of routine hearing assessment in older adults, while observational evidence indicates that hearing rehabilitation, particularly hearing aid use, may be associated with more favorable cognitive outcomes. Key Messages: Association vs. causation: hearing loss should be regarded as a robustly associated and potentially modifiable marker of dementia risk rather than a confirmed causal determinant. Neurological implication: from a neurological standpoint, central auditory dysfunction may reflect underlying brain vulnerability in aging rather than acting as a direct causal driver of AD. Clinical outlook: while causal effects of hearing rehabilitation have yet to be firmly established, prioritizing hearing health offers a promising and practical avenue for dementia prevention and clinical practice.

Schlagwörter

Stichwörter der Autor:innen

DementiaHearing lossNeurodegenerationPresbycusisβ-Amyloid

Autor:innen und Institutionen

  • Research Group on Neurodegenerative Diseases and Their Relationship with Neurosensory Alterations and Aging, Institute of Biomedicine of Castilla-La Mancha (IB UCLM), Department of Medical Sciences, School of Medicine o…
  • La Paz University Hospital/Carlos III/ Cantoblanco, Madrid, Spain.

Zitieren

APA

Fuentes-Santamaría, V., Díaz García, C. M., & Alvarado, J. C. (2026). Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation. Neurodegenerative Diseases, 1-14. https://doi.org/10.1159/000553216

Vancouver

Fuentes-Santamaría V, Díaz García CM, Alvarado JC. Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation. Neurodegenerative Diseases. 2026:1-14. doi:10.1159/000553216

BibTeX
@article{FuentesSantamara2026,
  author = {Fuentes-Santamaría, Verónica and Díaz García, Carmen María and Alvarado, Juan Carlos},
  title = {Hearing Loss as a Potentially Modifiable Marker of Dementia Risk: Neurological Evidence, Uncertainty, and Clinical Interpretation},
  journal = {Neurodegenerative Diseases},
  year = {2026},
  pages = {1--14},
  doi = {10.1159/000553216}
}
Kostenlos starten →